ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety of Selective Serotonin Reuptake Inhibitor (SSRI) in Overactive Bladder Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00902421
Recruitment Status : Completed
First Posted : May 15, 2009
Last Update Posted : August 26, 2010
Sponsor:
Information provided by:
Samsung Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2009
  Actual Study Completion Date : July 2009